# ---------------------------------------------------------------
#
# DATE: Sep 16 2015
# AUTHORS: Tran Dang Nguyen and Maciej F Boni
#
# This sample input file was created to get a first-time user up 
# and running quickly with the simulation.
#
# ---------------------------------------------------------------


# total number of days the simulation is run, including the burn-in period which we normally set to 4000
# days; during the burn-in period, no one receives malaria treatement and the system sets into a natural 
# equilibrium 
total_time: 11330

# length of burn-in period
start_treatment_day: 4000

# the day at which the simulation's reporting functionality begins collecting data for 
# the purposes of displaying it
start_collect_data_day: 4000

# probability that a symptomatic and infected individual seeks and receives antimalarial treatment
p_treatment: 0.600000

# this functionality works, but it was not used in any analyses for the 2015 LGH paper
number_of_locations: 1




# main scaling parameter for transmission, by location
# the last four terms are ignored when the number of locations is 1
beta: [0.2 , 1.4 , 1.4, 1.4, 1]

# this functionality works, but it was not used in any analyses for the 2015 LGH paper
# seasonality parameters, by location
seasonal_beta:
  a: [0, 0.25, 0.25, 0.25]
  phi: [200, 200, 200, 200]
  
  
# the last four terms are ignored when the number of locations is 1
population_size_by_location: [10000, 1000 , 1000, 1000, 500]

# probability that an infectious bite on a human causes a blood stage malaria infection
p_infection_from_an_infectious_bite: 0.1


# the simulation itself uses explicit ages and birthdays
# but for reporting purposes and for age-specific mortality calculations, individuals are grouped into the following age classes
number_of_age_classes: 15
age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 15, 20, 60, 100]


# this is only used for initializing the population structure at time 0
# the last four rows of the matrix below are ignored when the number of locations is 1
initial_age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 25, 35, 45, 55, 65, 100]
age_distribution_by_location: [
[0.0334, 0.0300, 0.0329, 0.0324, 0.0332, 0.0314, 0.0316, 0.0310, 0.0285, 0.0256, 0.0298, 0.0212, 0.0321, 0.0228, 0.0230, 0.1906, 0.1403, 0.0966, 0.0605, 0.0344, 0.0387],
[0.0334, 0.0300, 0.0329, 0.0324, 0.0332, 0.0314, 0.0316, 0.0310, 0.0285, 0.0256, 0.0298, 0.0212, 0.0321, 0.0228, 0.0230, 0.1906, 0.1403, 0.0966, 0.0605, 0.0344, 0.0387],
[0.0334, 0.0300, 0.0329, 0.0324, 0.0332, 0.0314, 0.0316, 0.0310, 0.0285, 0.0256, 0.0298, 0.0212, 0.0321, 0.0228, 0.0230, 0.1906, 0.1403, 0.0966, 0.0605, 0.0344, 0.0387],
[0.0334, 0.0300, 0.0329, 0.0324, 0.0332, 0.0314, 0.0316, 0.0310, 0.0285, 0.0256, 0.0298, 0.0212, 0.0321, 0.0228, 0.0230, 0.1906, 0.1403, 0.0966, 0.0605, 0.0344, 0.0387]
]

# below value indicates 37.25 births per 1000 individuals per year
birth_rate: 0.03725

# annual death rate (probability) by age group
death_rate_by_age: [0.053979329, 0.018935757, 0.006867257, 0.001124347, 0.001136455, 0.001606066, 0.001953783, 0.001530096, 0.001299153, 0.001068073, 0.000978264, 0.000978264, 0.0055, 0.0055, 0.04450]


# number of days to keep track total number of parasites in population
# in other words, the simulation stores 11 days of mosquitoes-biting-on-humans history
# if an individual is infected today, the infection type and probability will be based 
# on the biting that took place 11 days ago
number_of_tracking_days: 11


# probability of death for patients who are not treated or patients who experience a treatment failure (due to drug resistance, or otherwise)
mortality_when_treatment_fail_by_age: [0.040, 0.020,0.020,0.020,0.020,0.004,0.004,0.004,0.004,0.004,0.004, 0.001, 0.001, 0.001, 0.001]


# initial conditions for prevalence and drug resistance, by location
# parasite_type_id is the parasite genotype; 0 means completely sensitive to all drugs
# the parasite_type_id is a bit-string, so types 1, 2, 4, and 8 correspond to parasites 
# that have a resistance to a single drug
initial_parasite_info:
  - location_id: 0
    parasite_info:
      - parasite_type_id: 0
        prevalence: 0.1
#      - parasite_type_id: 2
#        prevalence: 0.1
#      - parasite_type_id: 4
#        prevalence: 0.1
  - location_id: 1
    parasite_info:
      - parasite_type_id: 0
        prevalence: 0.1
  - location_id: 2
    parasite_info:
      - parasite_type_id: 0
        prevalence: 0.1
  - location_id: 3
    parasite_info:
      - parasite_type_id: 0
        prevalence: 0.1
#      - parasite_type_id: 4
#        prevalence: 0.03


# functional but not used in 2015 LGH paper
# allows for the introduction of a specific parasite type at a specific time
introduce_parasite:
#  - location: 0
#    parasite_info:
#      - time: 4000
#        genotype_id: 1
#        number_of_cases: 5
#      - time: 4000
#        genotype_id: 2
#        number_of_cases: 5
#      - time: 4000
#        genotype_id: 4
#        number_of_cases: 5
#      - time: 4000
#        genotype_id: 8
#        number_of_cases: 5
#        


# periodic importation of drug-sensitive parasites; five new cases imported every seven days
introduce_parasite_periodically:
  - location: 0
    parasite_info:
      - duration: 7 
        genotype_id: 0
        number_of_cases: 5
        
        


# drug information below
#
# maximum_parasite_killing_rate: 
#       e.g. 0.999 means the drug can kill 99.9% of parasites in 1 day if a person has 
#       the highest possible drug concentration
#
# n: 
#       the slope of the linear portion of the conentration-effect curve
#
# EC50: 
#       the drug concentration which produces 50% of the parasite killing achieved at maximum-concentration
#       ( the expected starting concentration is 1.0 )
#
# age_specific_drug_concentration_sd: 
#       the actual drug concentration, per individual, will be drawn from a normal distribution with mean=1 and this sd.
#
# k: 
#       parameter that describes the change in the mutation probability when drug levels are intermediate
#       - set k=0.5 for a simple linear model where mutation probablity decreases linearly with drug concentration
#       - set k=2 or k=4 for a piecewise-linear model where mutation probability increases from high concentrations
#               to intermediate concentrations, and then decreases linearly from intermediate concentrations to zero
#
drugInfo:
  1:  # artemisinin (used for artemether, artesunate, and dihydroartemisinin)  
    half_life: 0.0
    maximum_parasite_killing_rate: 0.999
    n: 25
    EC50: 0.7
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [0]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 1
  2: # lumefantrine - use this for a standard simulation
    half_life: 4.5
    maximum_parasite_killing_rate: 0.99
    n: 20
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [1]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  3: # lumefantrine - for advanced users only
    half_life: 4.5
    maximum_parasite_killing_rate: 0.99
    n: 20
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [2]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  4: # lumefantrine - for advanced users only
    half_life: 4.5
    maximum_parasite_killing_rate: 0.99
    n: 20
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [3]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  5: # amodiaquine - for advanced users only
    half_life: 9.0
    maximum_parasite_killing_rate: 0.95
    n: 19
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.00
    mutation_position: [1]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  6: # amodiaquine - use this for a standard simulation
    half_life: 9.0
    maximum_parasite_killing_rate: 0.95
    n: 19
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [2]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  7: # amodiaquine - for advanced users only
    half_life: 9.0
    maximum_parasite_killing_rate: 0.95
    n: 19
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [3]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  8: # piperaquine - for advanced users only
    half_life: 28.0
    maximum_parasite_killing_rate: 0.9
    n: 15
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [1]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  9: # piperaquine - for advanced users only
    half_life: 28.0
    maximum_parasite_killing_rate: 0.9
    n: 15
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [2]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  10: # piperaquine - use this for a standard simulation
    half_life: 28.0
    maximum_parasite_killing_rate: 0.9
    n: 15
    EC50: 0.65
    age_specific_drug_concentration_sd: [0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4]
    mutation_probability: 0.005
    mutation_position: [3]
    k: 4
    resistance_cost_multiple_infection: 0.01
    isArtermisininDerivative: 0
  
# therapy info
# the drug_ids that make up the therapy, and the number of days that the therapy is prescribed for 
# testing day tells you the follow-up point at which it is determined if treatment failed or not
TherapyInfo:
  1:    
    drug_id: [1,2]
    dosing_days:  3
    testing_day: 28
  2:
    drug_id: [1,3]
    dosing_days:  3
    testing_day: 28
  3:
    drug_id: [1,4]
    dosing_days: 3
    testing_day: 28
  4:
    drug_id: [1,5]
    dosing_days: 3
    testing_day: 28
  5:
    drug_id: [1,6]
    dosing_days: 3
    testing_day: 28
  6:
    drug_id: [1,7]
    dosing_days: 3
    testing_day: 28
  7:
    drug_id: [1,8]
    dosing_days: 3
    testing_day: 28
  8:
    drug_id: [1,9]
    dosing_days: 3
    testing_day: 28
  9:
    drug_id: [1,10]
    dosing_days: 3
    testing_day: 28
  10:
    drug_id: [1,2]
    dosing_days: 3
    testing_day: 28
  11:
    drug_id: [1,6]
    dosing_days: 3
    testing_day: 28
  12:
    drug_id: [1,10]
    dosing_days: 3
    testing_day: 28


# drug-deployment strategy - simply uncomment below to turn on a particular strategy
StrategyInfo:
  #strategyName can be SFTStrategy / CyclingStrategy / MFTStrategy / AdaptiveCyclingStrategy
#  strategyName: SFTStrategy
  strategyName: CyclingStrategy
#  strategyName: MFTStrategy
#  strategyName: AdaptiveCyclingStrategy

  SFTStrategy:
    therapyID: [10]

  # cycle three ACTs in and out every five years
  CyclingStrategy:
    therapyID: [10,11,12]
    cycling_time: 1825
    
  # deploy three ACTs simultaneously
  MFTStrategy:
    therapyID: [10,11,12]
    distribution: [0.33334,0.33333,0.33333]

  # cycle three ACTs in and out - switch between ACTs when the fraction of patients experiencing
  # treatment failure get to the trigger value below
  # there is a one-year delay until the actual switch is made in the field (delay_until_actual_trigger)
  AdaptiveCyclingStrategy:
    therapyID: [10,11,12]
    trigger_value: 0.1
    delay_until_actual_trigger: 1
    turn_off_days: 50
    

# this number use to detemine whether a therapy is "useful" or not and it is used to calculate 
# the useful therapeutic duration of a therapy
TF_rate: 0.1

# definitions of some log parasite density levels
#
parasite_density_level:
  log_parasite_density_cured:        -2.699    # corresponds to 10,000 total parasites (0.002 per μl)
  log_parasite_density_from_liver:    -2.000   # corresponds to 50,000 total parasites (0.01 per μl)
  log_parasite_density_asymptomatic: 3         # corresponds to 1000 parasites per microliter of blood
  log_parasite_density_clinical:     4.301     # corresponds to 20,000 parasites per microliter of blood
  log_parasite_density_detectable:   1.000     # corresponds to 10 parasites per microliter of blood
  log_parasite_density_pyrogenic:    3.398     # corresponds to 2500 parasites per microliter of blood


immune_system_information:
  
  #rate at which antimalarial immune function increases when a host is parasitaemic
  b1: 0.00125
  
  #rate at which antimalarial immune function decreases when a host is parasitaemic
  b2: 0.0025
  
  # durations of infection of naive and fully-immune hosts. 
  # these parameters are used to calculate max and min killing rate by immune system
  duration_for_naive: 300
  duration_for_fully_immune: 60

  # initial conditions for the immune function of the population at time zero
  mean_initial_condition: 0.1
  sd_initial_condition: 0.1
  
  # (per year) age-dependent faster acquisition of immunity from age 1 to age 10
  immune_inflation_rate: 0.01   

  # mix and max probabilities of experiencing symptoms as a result of a new infection
  # the actual probability will depend on the host's immunity
  min_clinical_probability: 0.05
  max_clinical_probability: 0.99

  # slope of sigmoidal prob-v-immunity function (parameter z in supplement of 2015 LGH paper) 
  immune_effect_on_progression_to_clinical: 4
  
  # age at which immune function is mature
  age_mature_immunity: 10
  
  # parameter kappa in supplement of 2015 LGH paper
  factor_effect_age_mature_immunity : 1

# days from end of liver-stage infection to appearance of symptoms
days_to_clinical_under_five: 4
days_to_clinical_over_five: 6


# days that parasites develop mature gametocyte after exiting liverstage
# please read the documentation carefully - there are no explicit gametocytes in
# v3.0.2 of the simulation
days_mature_gametocyte_under_five: 4
days_mature_gametocyte_over_five: 6

# probability that a patient completes a course of treatment
p_compliance: 1

# this functionality works. It is used when p_compliance (above) is less than 1.
# It was not used in any analyses for the 2015 LGH paper where p_compliance is always 1.
# this guarantees that the minimum number of dosing days for a poorly-complying 
# patient is still 1
min_dosing_days: 1

# relative biting rates for individuals; uncomment "distribution: Exponential" to use an
# exponentially distributed biting rate
relative_bitting_info:
  max_relative_biting_value: 35
  number_of_biting_levels: 100
  biting_level_distribution:
  #  distribution: Exponential
    distribution: Gamma  
    Exponential:
      scale: 0.17
    Gamma:
      mean: 5
      sd: 10


# this functionality works, but it was not used in any analyses for the 2015 LGH paper
percentMovement: [
[0.0,   0.01,   0.01 ],
[0.01,  0.01,   0.01],
[0.01,  0.04,   0.02]
]

meanDaysToReturn: [
[3,   3,  3 ],
[7,   7,  7 ],
[14,  14, 14 ]
]


# do not change this
# this paramater was used in a different model version where gametocytes were
# modeled explicitly.  In v3.0.2, this need to be set to 0.2.
gametocyte_level_under_artemisinin_action: 0.2

# these values are based on Ross 2006 - these parameters determine the probability a mosquito
# becomes infected based on the host's asexual parasitaemia level
relative_infectivity:
  sigma: 3.91
  ro: 0.00031
  # on average 1 mosquito take 3 microliters of blood per bloodeal
  blood_meal_volume: 3

# probability to relapse after no treatment, or a treatment failure due to drug resistance
p_relapse: 0.01

# number of days before a relapse can occur
relapse_duration: 30

# relapse rate - used to increase the parasite density after a treatment failure (at the drug clearance day)
# multiply by sqrt(20) per day
relapseRate: 4.4721

# minimum update frequency for a host's attributes (esp. parasite density) is every 7 days, or
# more frequently if other events are occurring at this time
update_frequency: 7

#report to GUI and console every 30 days
report_frequency: 30

# if an infected and asymptomatic host is bitten and infected by a new 
# parasite clone, this setting allows the new infection to cause symptoms
allow_new_coinfection_to_cause_symtoms: true


# this functionality works, but it was not used in any analyses for the 2015 LGH paper
spatial_information:
  max_relative_moving_value: 35
  number_of_moving_levels: 100
  moving_level_distribution:
  #  distribution: Exponential
    distribution: Gamma  
    Exponential:
      scale: 0.17
    Gamma:
      mean: 5
      sd: 10
  circulation_percent: 0.0
  length_of_stay:
    mean: 5
    sd: 10
    
# this functionality works, but it was not used in any analyses for the 2015 LGH paper
spatial_external_population_information:
  max_relative_moving_value: 35
  number_of_moving_levels: 100
  moving_level_distribution:
  #  distribution: Exponential
    distribution: Gamma  
    Exponential:
      scale: 0.17
    Gamma:
      mean: 5
      sd: 10
  circulation_percent: [0.0, 0.01, 0.01, 0.01, 0.01 ]
  length_of_stay:
    # drawn from gamma distribution?
    mean: 5
    sd: 10    
  daily_EIR: [0.01,0.01,0.01,0.01,0.1]
  seasonal_EIR:
    a: [0.25,0.25,0.25,0.25]
    phi: [200,200,200,200]
    
# this functionality works, but it was not used in any analyses for the 2015 LGH paper
tme_info:
  tme_starting_day: 0
  mda_coverage: [0.8, 0.8, 0.8, 0.8]
  mda_duration: [4, 4, 4, 4]
  
# free recombination among the drug resistance loci
using_free_recombination: true
#using_free_recombination: false

# the current treatment failure rate as observed in the population is not really
# today's treatment failure rate, as these data are never assembled that quickly in
# real life; rather, it is the average treatment failure rate observed over the 
# past 60 days
tf_window_size: 60

# special function to make the mean biting rate (across hosts) depend on age
using_age_dependent_bitting_level: false

# special function which makes the probability of an infection (resulting 
# from an infectious mosquito bite) age-dependent
using_variable_probability_infectious_bites_cause_infection: false

fraction_mosquitoes_interrupted_feeding: 0.1

